| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a3a48f9c764182f11efb37ec6f33ee24 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-485 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6813
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-715 |
| filingDate |
2012-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a71d6b8b547930445dbe3fc5efce4090
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17731e935d1fa451a47c6db806ca554f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e45805e074b1169c4307c905a65bb233 |
| publicationDate |
2012-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2012149070-A |
| titleOfInvention |
Epidermal growth factor receptor mutation |
| abstract |
An epidermal growth factor receptor ("EGFr") mutation, mutant EGFr polypeptide is provided. Mutations of epidermal growth factor receptor (EGFr), phosphatidylinositol 3′-kinase (“PI3K”) and B-Raf. A method of treating a tumor containing a mutated EGFr using a human monoclonal antibody against EGFr. Methods and kits for confirming the presence of one or more mutant EGFr, mutant PI3K and / or mutant B-Raf in a sample and mutant EGFr, mutant PI3K and / or mutant B- Methods and kits for treating diseases or conditions associated with the presence of Raf. A method of treating a tumor comprising mutant EGFr, mutant PI3K and / or mutant B-Raf. [Selection figure] None |
| priorityDate |
2005-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |